Brief: Vertex And Entrada Therapeutics Establish Collaboration To Discover And Develop Endosomal Escape Vehicle Therapeutics For Myotonic Dystrophy Type 1

Entrada Therapeutics

08/12/2022 13:39

Dec 8 (Reuters) - Entrada Therapeutics Inc  TRDA.O :
    * VERTEX AND ENTRADA THERAPEUTICS ESTABLISH COLLABORATION TO
DISCOVER AND DEVELOP ENDOSOMAL ESCAPE VEHICLE (EEV) THERAPEUTICS
FOR MYOTONIC DYSTROPHY TYPE 1 (DM1)
    * ENTRADA THERAPEUTICS INC - TO RECEIVE $224 MILLION UPFRONT
PAYMENT AND $26 MILLION EQUITY INVESTMENT, AS WELL AS POTENTIAL
MILESTONE PAYMENTS AND ROYALTIES
    * ENTRADA THERAPEUTICS INC - GLOBAL COLLABORATION INCLUDES
ENTR-701, ENTRADA'S EEV-INVESTIGATIONAL CANDIDATE FOR TREATMENT
OF DM1
    * ENTRADA - ELIGIBLE TO RECEIVE UP TO $485 MILLION FOR
SUCCESSFUL
ACHIEVEMENT OF CERTAIN RESEARCH, DEVELOPMENT, REGULATORY AND
COMMERCIAL MILESTONES

Source text for Eikon:  ID:nBw2KHKt8a 
Further company coverage:  TRDA.O 
 ((Reuters.Briefs@thomsonreuters.com;))